Search Results

You are looking at 1 - 10 of 1,206 items for :

  • brain development x
  • All content x
Clear All
Free access

Stijn L J Van Herck, Stijn Geysens, Edward Bald, Grazyna Chwatko, Evelyne Delezie, Elham Dianati, R G Ahmed, and Veerle M Darras

, we have used the chicken embryo to study the effect of maternal MMI treatment on the developing embryo. It has been shown earlier that MMI is taken up from the egg by the embryo and is capable of disturbing development, including brain development

Free access

Juan Bernal

Introduction The actions of thyroid hormones (TH) on brain develop­ment and function are among the more relevant of these hormones, strongly influencing neuromotor performance, cognition and mood. Multiple conditions cause impaired TH action

Free access

Yuhui Liu, Le Zhang, Jing Li, Zhongyan Shan, and Weiping Teng

Introduction It is well known that iodine is a trace element essential for the synthesis of triiodothyronine (T 3 ) and thyroxine (T 4 ), which play a crucial role in the process of early growth and development of most organs, especially the brain

Free access

Meredith A Kelleher, Hannah K Palliser, David W Walker, and Jonathan J Hirst

( Lackman et al . 2001 ). Placental insufficiency and IUGR have many implications for foetal brain development. Along with clinical observations, animal studies have also revealed the morphological changes and neurological impairments associated with foetal

Restricted access

C. P. PHELPS and J. H. LEATHEM

SUMMARY

Some developmental and functional manifestations of thyroxine (T4) administered on the first 2 days of postnatal life were studied in the female rat. Brain myelinogenesis estimated by brain esterified cholesterol concentration, and brain myelin age estimated by brain total cholesterol concentration, were subsequently determined. Thyroxine treatment resulted in a greater concentration of esterified cholesterol in the brain than saline treatment, but the latter appeared to delay the normal increase shown by non-injected controls. Thyroxine treatment resulted in total and free cholesterol levels similar to those of non-injected controls, these again being greater than those in saline-treated rats. Cholesterol concentrations in liver and serum were not affected by T4 or saline treatment.

Administration of T4 to female rats before administration of 1·25 mg testosterone propionate on day 7 resulted in an ovarian and uterine weight response to human chorionic gonadotrophin (HCG, 1 i.u./day on days 23–26) on day 27 that was greater than that in litter-mates given saline at birth before testosterone propionate and HCG treatment. Postnatal T4 treatment alone in the female was also associated with a reduced thyroid and pituitary gland enlargement after 7 days of propylthiouracil feeding (0·015% in tap water, days 24–31 of life) when compared with either saline or non-injected controls.

Restricted access

M. Hubank, A. K. Sinha, D. Gullo, and R. P. Ekins

ABSTRACT

Tri-iodothyronine (T3) binding studies were performed on neuronal and glial nuclei prepared from developing rats brain by discontinuous sucrose gradient centrifugation. Maximum binding capacities (MBC) and dissociation constants (K d) were obtained from Eadie-Hofstee plots of transformed data. An ontogenic study on nuclei prepared from whole brain revealed that on day 5 after birth, glial nuclear MBC was 1774±201 (s.e.m.) fmol/mg DNA compared with 974±117 fmol/mg DNA for the neurones (P<0·01). Although diminishing to 667±112 fmol/mg DNA by day 21, alterations in neuronal MBC over the neonatal period were not statistically significant, whereas glial MBC diminished steadily to 557±133 fmol/mg DNA in glial nuclei (P<0·05). Over the same period, a significant reduction in K d was noted only in the glia, from 3·17±0·40 to 1·83±0·34 nmol/l (P<0·03). Ligand specificity of the receptor in both nuclear types on day 21 was tri-iodoacetic acid > T3 > thyroxine > 3,3′,5′-T3, but this was less clearly demonstrated at day 5.

Regional studies on days 15 and 21 demonstrated that for both neuronal and glial nuclei, receptors are concentrated in the cerebral cortex and diminish in a cranio-caudal direction. Cerebral glial MBC on day 21 was 2215±147 fmol/mg DNA, at this stage still exceeding the cerebral neuronal capacity of 1111±207fmol/mg DNA. The results indicate that neonatal glia may respond directly to thyroid hormones via nuclear receptor binding, and that receptors are predominantly located in the cortex. Decreases in average MBC in the late neonate may be due to increases in the numbers of cells containing fewer nuclear receptors.

Journal of Endocrinology (1990) 126, 409–415

Free access

Michela Campolo, Akbar Ahmad, Rosalia Crupi, Daniela Impellizzeri, Rossana Morabito, Emanuela Esposito, and Salvatore Cuzzocrea

attenuate the development of acute brain injury 1 and 6 h after TBI. On the contrary, combination therapy with melatonin and DEX reduced the degree of brain injury and inflammatory cell infiltration (D). The image shown is representative of at least three

Free access

J Patel, K Landers, H Li, R H Mortimer, and K Richard

receptor activation in the brain. Ontogenesis of thyroid hormone action in fetal development There is growing evidence that thyroid hormones act on embryological and fetal tissues early in development. Thyroid hormone and associated receptors are

Free access

Hiranya Pintana, Nattayaporn Apaijai, Nipon Chattipakorn, and Siriporn C Chattipakorn

SL 1991 Development of glutamate neurotoxicity in cortical cultures: induction of vulnerability by insulin . Brain Research. Developmental Brain Research 62 293 – 296 . ( doi:10.1016/0165-3806(91)90179-M ) Stranahan AM Norman ED Lee K

Free access

Han Yan, Matthew Mitschelen, Georgina V Bixler, Robert M Brucklacher, Julie A Farley, Song Han, Willard M Freeman, and William E Sonntag

IGF1 deficiency and replacement on brain gene expression that we expect contribute to long-term modifications in brain development, function, learning and memory. To this end, we used a unique model of GH/IGF1 deficiency (the Lewis dwarf ( dw/dw ) rat